COMMUNIQUÉS West-GlobeNewswire
-
OSE Immunotherapeutics Presents Selective SIRP-alpha antibodies: OSE-172, a next-generation myeloid checkpoint inhibitor at the World Immunotherapy Congress
30/10/2018 - 18:00 -
NEOVACS : HALF-YEAR 2018 FINANCIAL RESULTS
30/10/2018 - 17:51 -
NEOVACS : RÉSULTATS SEMESTRIELS 2018
30/10/2018 - 17:51 -
Composition of the Nomination Committee of Orion Corporation
30/10/2018 - 17:31 -
MEDIA ADVISORY: Canadian Afghanistan War Veteran and cannabis industry leaders to appear before Senate Subcommittee on Veterans Affairs
30/10/2018 - 17:00 -
Solon Eiendom ASA – Daglig leder Andreas Martinussen har sagt opp sin stilling i Solon Eiendom ASA
30/10/2018 - 16:30 -
Medibio Limited Quarterly ASX Update and Cashflows
30/10/2018 - 15:52 -
Exagen Diagnostics to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
30/10/2018 - 15:30 -
Cytori Therapeutics Announces Receipt of Puregraft® Royalty Milestone
30/10/2018 - 14:28 -
Olainfarm’s Presentation For Investors Available Online Today At 17.30 EET at LHV Pank’s Facebook Profile
30/10/2018 - 14:12 -
Hemostemix Announces OTCQB Listing and DTC Eligibility
30/10/2018 - 14:07 -
Predictive Technology Group Appoints Industry Veteran John E. Sorrentino as Chairman
30/10/2018 - 14:00 -
Pure Pharmacy Group to Offer Molecular You’s Preventive Health Assessments across all Lower Mainland Locations
30/10/2018 - 14:00 -
NewLink Genetics to Participate in the Stifel 2018 Healthcare Conference
30/10/2018 - 14:00 -
NSS Labs Announces Results of Second Edition of 2018 Data Center Intrusion Prevention System Group Test
30/10/2018 - 14:00 -
Progressive Care Enters into Definitive Agreements to Purchase Property for Third Pharmacy Location in South Florida
30/10/2018 - 14:00 -
Advantis Corp. Looking to Team Up For MJBIZCON
30/10/2018 - 14:00 -
Abattis Bioceuticals Offers Comfort to Those Suffering with Chronic Pain & Inflammation -- CFN Media
30/10/2018 - 14:00 -
New Study Cites 82 Percent Mortality and 56 Percent Rehospitalization Reductions 30 Days After Therapy Guided by Daxor’s BVA-100 Blood Volume Analyzer in Acute Heart Failure Patients
30/10/2018 - 13:30
Pages